Artificial intelligence comes of age for gerontology research

Written by Francesca Lake

The Chief Science Officer of the Biogerontology Research Foundation (BGRF; Cornwall, UK) has presented new research on artificial intelligence (AI) for drug discovery at the NVIDIA Graphics Technology Conference (San Jose, CA, USA, 8–11 May 2017), which may have use in the development of new drugs against neurodegenerative disease and other age-related disorders. The presentation was alongside AI scientists from Insilico Medicine (MD, USA) and discussed generative adversarial networks (GANs) in drug discovery. Deep learning, and GANs in particular, have demonstrated surprising results. The BGRF was the first to apply GANs to generating anticancer drugs and has suggested that biogerontology...

To view the full article, please register now for access

It's completely free